Co-Diagnostics, Inc. Payments for Repurchase of Initial Public Offering
Co-Diagnostics, Inc. (CODX) reported Payments for Repurchase of Initial Public Offering of $592.76 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2020-03-30
- Co-Diagnostics, Inc. payments for repurchase of initial public offering for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Co-Diagnostics, Inc. payments for repurchase of initial public offering for the quarter ending 2019-09-30 was $0.00.
- Co-Diagnostics, Inc. payments for repurchase of initial public offering for the quarter ending 2019-06-30 was $0.00.
- Co-Diagnostics, Inc. payments for repurchase of initial public offering for the quarter ending 2019-03-31 was $592.76K.
- Co-Diagnostics, Inc. payments for repurchase of initial public offering for fiscal 2019 was $592.76K, a 285.30% increase from fiscal 2018.
- Co-Diagnostics, Inc. payments for repurchase of initial public offering for fiscal 2018 was $153.84K.
| Period end | Payments for Repurchase of Initial Public Offering 3 month | Payments for Repurchase of Initial Public Offering 6 month | Payments for Repurchase of Initial Public Offering 9 month | Payments for Repurchase of Initial Public Offering 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $592.76K 10-K · filed 2020-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $592.76K 10-Q · filed 2019-11-12 | $615.62K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $592.76K 10-Q · filed 2019-08-14 | $615.62K derived: sum of 3 quarters · filed 2020-03-30 | |
| 2019-03-31 | $592.76K 10-Q · filed 2019-05-14 | $615.62K derived: sum of 2 quarters · filed 2020-03-30 | ||
| 2018-12-31 | $22.86K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $153.84K 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $130.99K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |